GNTA Stock — Genenta Science SpA ADR

Genenta Science SpA ADR (GNTA)

Updated October 16, 2026.

GNTA is a Stock. Total return is -93.9% over the past 4.8 years, 167.3 points behind SPY at 73.4%.

Genenta Science is an Italian holding company that acquires ownership stakes in privately held companies operating in national-security-regulated sectors, including aerospace, defense, national security, and biotechnology/biosecurity. The company does not currently have an established distribution schedule. This security may appeal to investors seeking exposure to Italian defense and security sector consolidation.

GNTA performance versus SPY

Price and return data through 2026-10-16.

Total return is -93.9% over the past 4.8 years, 167.3 points behind SPY at 73.4%. Over the past year its total return — price change plus distributions reinvested — is -79.0%. Its deepest 1-year drawdown was 90.6%.

GNTA key facts

Asset type

Stock

Asset class

Equity

Inception date

12/15/2021

Distribution frequency

None

Last close

$0.68 (as of 2026-10-16)

Market cap

$32,546,379

Average volume

39480.0

Beta

0.755

Payout ratio

0.0%

EPS

$-0.37

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

GNTA risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 90.6%.

Who may consider GNTA — and who may not

It is a weaker fit for investors who need monthly cash flow (GNTA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on GNTA

• All tickers starting with G

Tagged: Healthcare.

Frequently asked questions